Literature DB >> 20974311

Author reply: Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.

William T Cefalu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20974311      PMCID： PMC4474374          DOI： 10.1016/j.metabol.2010.07.017

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

1.  Chromium treatment has no effect in patients with poorly controlled, insulin-treated type 2 diabetes in an obese Western population: a randomized, double-blind, placebo-controlled trial.

Authors:  Nanne Kleefstra; Sebastiaan T Houweling; Frank G A Jansman; Klaas H Groenier; Rijk O B Gans; Betty Meyboom-de Jong; Stephan J L Bakker; Henk J G Bilo
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

Review 2.  Current concepts about chromium supplementation in type 2 diabetes and insulin resistance.

Authors:  Zhong Q Wang; William T Cefalu
Journal:  Curr Diab Rep       Date:  2010-04       Impact factor: 4.810

3.  Characterization of the metabolic and physiologic response to chromium supplementation in subjects with type 2 diabetes mellitus.

Authors:  William T Cefalu; Jennifer Rood; Patricia Pinsonat; Jianhua Qin; Olga Sereda; Lilian Levitan; Richard A Anderson; Xian H Zhang; Julie M Martin; Corby K Martin; Zhong Q Wang; Bradley Newcomer
Journal:  Metabolism       Date:  2009-12-22       Impact factor: 8.694

4.  Chromium picolinate enhances skeletal muscle cellular insulin signaling in vivo in obese, insulin-resistant JCR:LA-cp rats.

Authors:  Zhong Q Wang; Xian H Zhang; James C Russell; Matthew Hulver; William T Cefalu
Journal:  J Nutr       Date:  2006-02       Impact factor: 4.798

5.  Oral chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA corpulent) rats.

Authors:  William T Cefalu; Zhong Q Wang; Xian H Zhang; Linda C Baldor; James C Russell
Journal:  J Nutr       Date:  2002-06       Impact factor: 4.798

6.  Phenotype of subjects with type 2 diabetes mellitus may determine clinical response to chromium supplementation.

Authors:  Zhong Q Wang; Jianhua Qin; Julie Martin; Xian H Zhang; Olga Sereda; Richard A Anderson; Patricia Pinsonat; William T Cefalu
Journal:  Metabolism       Date:  2007-12       Impact factor: 8.694

7.  Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes.

Authors:  Cesar A Albarracin; Burcham C Fuqua; Joseph L Evans; Ira D Goldfine
Journal:  Diabetes Metab Res Rev       Date:  2008 Jan-Feb       Impact factor: 4.876
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.